Photomedicine for Hair Regrowth is well known, however recent research suggests much higher doses are needed to maximize the hair regrowth effect – e.g., >=20J/cm2 compared with 4J/cm2 past target; see “Various Wavelengths of Light-Emitting Diode Light Regulate the Proliferation of Human Dermal Papilla Cells and Hair Follicles via Wnt/β-Catenin and the Extracellular Signal-Regulated Kinase Pathways” , Ann Dermatol. 2017 Dec; 29(6): 747–754. Published online 2017 Oct 30. doi: 10.5021/ad.2017.29.6.747 .
In light of this research, the figure shows where some common photomed devices for hair regrowth may lie on the revised dose-response curve:
Michael Rabin, MD, MBA, CEO
26 Alpha Park
Highland Heights, OH 44143
About LaserCap® Company – Transdermal Cap, Inc. was formed in 2006 by co-inventors Michael Rabin, MD and M.I.T.-trained optical physicist David Smith, PhD, in collaboration with Harvard-based photomedicine expert Michael Hamblin, PhD and internationally acclaimed hair restoration physician Robert Haber, MD, to develop innovative light-based devices for the Global Beauty & Health Industries. Its first commercial product is LaserCap for women with thinning hair or at risk for thinning hair, a condition that affects up to 50% of adult women. Patents pending, Copyright 2009 Transdermal Cap, Inc.
LaserCap® now with SuperBright™ & SuperCool™ patent-pending technologies to boost photomed output power; on certain models. /Michael Rabin, MD 5/22/2019